Viewing data from:

POLYETHYLENE GLYCOL 3350

ANDA

POLYETHYLENE GLYCOL 3350 | A091077 | NOVEL LABORATORIES INC

2 strengths0 unique patents0 unique exclusivities

Drug Pricing (NADAC)

National Average Drug Acquisition Cost — Week of 2026-07-15 | 4 NDCs

Highest NADAC/Unit

$0.0245

per gm

Lowest NADAC/Unit

$0.0204

per gm

Brand NDCs

Generic NDCs

NDC Description	NADAC/Unit	Unit	Type	Generic NADAC	Effective
68001050555POLYETHYLENE GLYCOL 3350 POWD	$0.0245	GM	Generic	—	2026-06-17
43386031208GAVILAX POWDER	$0.0245	GM	Generic	—	2026-06-17
68001050569POLYETHYLENE GLYCOL 3350 POWD	$0.0204	GM	Generic	—	2026-06-17
43386031214GAVILAX POWDER	$0.0204	GM	Generic	—	2026-06-17

Source: NADAC (data.medicaid.gov). Prices reflect national average acquisition costs for retail community pharmacies.

VA Federal Supply Schedule

Government-negotiated contract prices | 2 NDCs (2 FSS)

Lowest Price

$8.13

Highest Price

$12.60

FSS NDCs

Big4 NDCs

Description	Price	Type	Vendor	Contract End
43386-0312-08POLYETHYLENE GLYCOL 3350 PWDR,ORAL	$8.13	FSS	Golden State Medical Supply, Inc.	06/14/2028
43386-0312-14POLYETHYLENE GLYCOL 3350 PWDR,ORAL	$12.60	FSS	Golden State Medical Supply, Inc.	06/14/2028

Source: VA Federal Supply Schedule (va.gov). Prices are government-negotiated contract prices.

API Supply Chain4 active DMFs

4 active API suppliers hold Drug Master Files for this ingredient.

BASF CORPPOLYETHYLENE GLYCOL 3350

DMF 169462003

AVESTA PHARMA PVT LTDPOLYETHYLENE GLYCOL 3350 USP

DMF 274192013

CLARIANT CHEMICALS (HUIZHOU) LTDPOLYETHYLENE GLYCOL 3350 USP/NF

DMF 323552018

PHARCOS SPECIALITY LTDPOLYETHYLENE GLYCOL 3350 USP

DMF 413202025

Source: FDA Drug Master Files (fda.gov). Type II API DMFs matched by ingredient.

Approval Letters

1 letter from Drugs@FDA

Date	Submission	Document
Oct 14, 2009	ORIG -1	View Letter (PDF)

Source: Drugs@FDA application documents.

Products (2)

Sort:

#001 — 17GM/SCOOPFUL

0 patents0 exclusivities▴

FOR SOLUTION;ORAL | Approved: Oct 6, 2009

No patent or exclusivity listings for this strength.

#002 — 17GM/PACKET

0 patents0 exclusivities▾

FOR SOLUTION;ORAL | Approved: Jun 27, 2011